Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
about
Pathogenesis of human immunodeficiency virus infectionCommon immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytesThe role of infection in miscarriagePeptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virusMonitoring of immune response by blood serum profiling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Peptide design by artificial neural networks and computer-based evolutionary search.Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteinsComparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based arrayRetention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope.Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infectionGenomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.Practical diagnostic testing for human immunodeficiency virus.Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoproteinAnalysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virusMapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.Localization of immunogenic domains in the human immunodeficiency virus type 2 envelopeSynthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzeesEnvelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.Retroviral infections transmitted by blood transfusionComparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis.Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African seraImmunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2.Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.Differential diagnosis of human retrovirus infections in the laboratory.Immunobiology of the HIV envelope.HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid testsB- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.ENZYME LINKED IMMUNOSORBENT ASSAYS REVISITED.FALSE POSITIVE ELISA RESULTS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION: A Case Report.Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus.Seroepidemiology of human retroviruses in Ogun State of Nigeria.
P2860
Q24634681-BC1FB9FB-4956-4B66-9171-907775C5AFDDQ24648466-57CFA320-285C-44D1-90B1-93D47673EA21Q26783142-E3C66C19-293D-4C6B-9A78-48C9ACE264C4Q27485919-B1F664A2-0C39-4387-88AF-6263BDB183E4Q30979633-26129E2C-B294-45D0-A04F-FFAD15BB39F2Q32000547-67B458D1-0B34-489F-8EC8-1376F4C3A009Q33686306-3001281F-C167-46C3-87D9-858645833737Q33880904-1015B252-88A6-4782-AF7F-FFEBB5103E01Q34430673-173C0509-0FF9-455C-9BEB-3DC374E5C243Q35057791-9FA238F7-4F73-43D7-B2CA-64681138726AQ35886295-7BA28766-9CC9-40B6-BA24-ABF311033A82Q35964833-F044AFCE-AE2A-4644-A145-497542BB00E6Q36629169-EEA35E0A-3729-4444-BB90-6C437BDCDBE7Q36632724-CB83FB5A-CA72-499F-B1A9-F7A4D03DD18CQ36644697-E4C1842D-DBC2-4820-BE29-AABE26CAC7E3Q36648889-9791AC47-E79A-4057-B6A3-2E5B0BC1A0B7Q36680833-03994923-1172-40E2-98B4-C9F502130149Q36683506-935CA0E2-6FC0-4B86-8081-2C7DDE0FD4C1Q36689226-9157C475-3A83-4530-80D6-9B7FB7E17F31Q36797042-D19C6AF9-0AD7-42A7-972C-C5945C8F4C2BQ36797905-577F7600-2953-4290-B24F-8854C5F645FDQ36800188-15FBE892-2B26-4720-9E37-3FC08A10E521Q36811030-A4D0C80D-47FC-470D-B728-1D6CD7D8657AQ36988143-20F45005-6DF0-4A29-A416-9235CF022BDBQ37114616-89536759-C59C-4335-91FC-2FBCFC97205AQ37124076-64DBA581-3DC7-4B14-88BF-8C77F1CC9255Q37149464-DF2F36E4-890E-410E-B758-3E6D2E6D4E61Q37162406-3C4C0276-8498-4D9E-9EE6-1BD1BADC5FABQ37243770-6CF51679-ACE3-4EC4-857F-78745DF7D1D6Q37541342-51F56891-AE30-4698-BD52-D28BBE7E69EEQ38286541-2DC38A41-84F8-468D-8571-1070B1422DE3Q38705312-0D08EA64-172C-4B32-92C3-6A2A0EAAA964Q38973555-03AE76D0-DC17-49BD-8B92-09EEAC7134BFQ39507423-29CF6620-A9CB-492B-830C-259DB1E8AD59Q40130078-D2AC9D4A-CC50-47A3-8AA2-51D3E0E3C70CQ40180278-BBEC0FC3-4E7E-482B-B417-3E40B368B12BQ41148896-0A24BE8C-71BD-42C9-B650-DA324801B50CQ41149058-61CD8F16-27BE-4DA9-9F96-F47E5CBD449EQ45767529-50937705-699C-46A2-9587-8A60E5919080Q46589717-02CDEA58-CDB7-4E20-92DC-AF35249D08E1
P2860
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@ast
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@en
type
label
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@ast
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@en
prefLabel
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@ast
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@en
P2093
P356
P1433
P1476
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
@en
P2093
Gnann JW Jr
McCormick JB
Mitchell S
Oldstone MB
P304
P356
10.1126/SCIENCE.2888192
P407
P577
1987-09-01T00:00:00Z